Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast ...
Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN. Lekha Gupta Clinical Research Firm ICON Faces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback